Bloomberg Audio Studios, podcasts, radio news.
The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.
Let's take a look at some stocks on the move today in Europe. I'm Stephen Carroll and I'm joined by Bloomberg's Breaking News editor Louise Louise. Good morning. Let's start with the miners. Their names like Fresnelo are rallying. What's behind us?
Indeed, ye, Fresnelo is leading the foot See one hundred with its gains, and then also up there among the top rises on the FOOTWEO hundred, you've got en Devor Mining, on the foot Sea two fifty, you've got Hotshild Mining, Pan African Resources, and essentially they're all rallying after gold and silver have a hit record highs. Obviously, this is on the back of you know, the US Justice Department threatening the FED with cron indictment. There's independence concerns around that.
There's also protests in Iran, and so there's you know, this this stronger demand for safer assets and this is pushing precious metals up, and then with that the miners. So then as I say, they're they're really leading the gains across the indexes this morning in London.
Okay, so that's on Fresnillo and miners this morning. We're also watching shares in Barclays though, falling after the President Trump's comments about credit card rates.
Indeed, yeah, so on the other end of the spectrum, we've got Barkleays the biggest loser on the foot see hundred in London this morning. As you say, falling fell as much as four point eight percent this morning on the back of these Trump comments. These were said on Sunday, essentially saying that credit card lenders would be in violation of the law if they don't do what he says or he suggests and cap interest rates at ten percent
for one year. So he set a January twentieth deadline for compliance on that for these banks to comply on that. It's not you know, his demand is not backed up by legislation, So it's not totally clear how these banks would be breaking the law if they didn't comply with what Trump says. But obviously it's bringing the into the crosshairs, and you know, comments like that from Trump obviously move markets a lot mover stop prices a lot. So Barclays is the British one that's kind of moving on the
back of that. It's very exposed. It's got a US credit card business. It makes about a third of its net revenue in the US. So shares being pulled down into the red quite heavily on the back of those comments.
Okay, and a huge surge in shares in the French biotech for an abbi vax what's going on.
Indeed, as much as thirty one percent they're gains this morning. This is about speculation about a possible takeover. So it's already kind of been viewed as an attractive acquisition asset. Their shares have risen hugely over the past year, almost two thousand percent, on the view that it would be
an attractive acquisition target. And this is partly based around they're expecting clinical trial results this year for a key drug, for an experimental drug for inflammatory bowders, and so because of that, you know, there's analyst saying that you can't ignore that this would be one of the most used products in the next decade. Because of that, it's becoming
or expecting to become an attractive acquisition target. The latest speculation being reported by French media is that Eli Lilly is ready to make an offer and that's for fifteen billion euros to buy it. The company hasn't confirmed this, but that is what's being reported, and you know they've they've declined to comment about that. But as I say, it's being positioned as a takeover target. There's eyes on it.
Shares a surging on the back of this, so we'll becoming a close eye for this potential big MNA deal.
The Stock Mover's report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.